Actavis Inc. (ACT) reported a first-quarter net loss attributable to shareholders of $102.8 million or $0.79 per share, compared to profit of $54.8 million or $0.43 per share last year. The company noted that the current quarter loss includes $270 million, or $1.77 per share, of charges related to the acquisitions of the legacy Actavis Group in November of 2012 and Uteron Pharma SA in January of 2013.
Adjusted profit per share was $1.99 compared to $1.64 prior year. Net revenues increased to $1.90 billion from $1.52 billion last year.
On average, 19 analysts polled by Thomson Reuters expected the company to report profit of $1.86 per share for the quarter. Analysts' estimates typically exclude special items. Analysts expected revenue of $1.97 billion for the quarter.
The company increased its forecast for 2013 adjusted earnings per share in the range of $8.10-$8.50. Actavis estimates total net revenue for 2013 of approximately $8.1 billion. Analysts expect the company to report fiscal 2013 profit per share of $8.09 on revenue of $8.09 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.